EWN-30521-54191 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Dose 1 — Pfizer-BioNTech
2021-01-10
Dose 2 — Pfizer-BioNTech
2021-01-12
Registered in v-safe
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-17
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-24
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-22
Survey response — day 42, dose 2
MedDRA: Pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Body aches and pains

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-22
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-07-11
Survey response — 6 months, dose 2
MedDRA: Anaemia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe anemia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-11
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-13
Call 1 — Left Voicemail
2022-01-10
Survey response — 12 months, dose 2
MedDRA: Anaemia, Haemoglobin decreased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Severe anemia requiring iron infusions to raise my hemoglobin.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-10	Pfizer-BioNTech

Call center

4 call center cases

1 unsuccessful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 4 — day 42, dose 2

2021-02-22

Symptoms: Body aches and pains

Release 9 — 6 months, dose 2

2021-07-11

Symptoms: Severe anemia

Release 10 — 12 months, dose 2

2022-01-10

Symptoms: Severe anemia requiring iron infusions to raise my hemoglobin.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anaemia	✓	✓	✓
SD	Haemoglobin decreased	·	·	✓
SD	Pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release